Show items per page
Elements: 7
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Assessment of cardiovascular safety of anti-osteoporosis drugs Fuggle, N. R.; Cooper, C.; Harvey, N. C.; Al-Daghri, N.; ... Reginster, J. Y. 2020
add to browser selection
What is the predictive value of MRI for the occurrence of knee replacement surgery in knee osteoarthritis? Pelletier, J.-P.; Cooper, C.; Peterfy, C.; Reginster, J.-Y.; ... Guermazi, A. 2013
add to browser selection
Value of biomarkers in osteoarthritis: current status and perspectives Lotz, M.; Martel-Pelletier, J.; Christiansen, C.; Brandi, M.-L.; ... Reginster, J.-Y. 2013
add to browser selection
Relationship between 3-month changes in biochemical markers of bone remodelling and changes in bone mineral density and fracture incidence in patients treated with strontium ranelate for 3 years Bruyere, O.; Collette, J.; Rizzoli, René; Decock, C.; ... Reginster, J-Y 2010
add to browser selection
The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES) Bruyere, O.; Kanis, J. A.; Ibar-Abadie, M-E; Alsayed, N.; ... Reginster, J-Y 2010
add to browser selection
Management of osteoporosis in the elderly Rizzoli, René; Bruyere, O.; Cannata-Andia, J. B.; Devogelaer, J -P; ... Reginster, J -Y 2009
add to browser selection
Post-fracture management of patients with hip fracture: a perspective Bruyere, O.; Brandi, M-L; Burlet, N.; Harvey, N.; ... Akesson, K. 2008